US 10308934
Compositions for modulating Ataxin 2 expression
granted A61PA61P21/00A61P25/00
Quick answer
US patent 10308934 (Compositions for modulating Ataxin 2 expression) held by Ionis Pharmaceuticals, Inc. expires Mon May 30 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Ionis Pharmaceuticals, Inc.
- Grant date
- Tue Jun 04 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 30 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 39
- CPC classes
- A61P, A61P21/00, A61P25/00, A61P25/16, A61P25/28